Mobile

A multi-center, open label, single-arm study to investigate the safety and efficacy of daily oral administration of 2 mg dienogest tablets for the treatment of endometriosis in adolescents over a tre...

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-017169-53

A multi-center, open label, single-arm study to investigate the safety and efficacy of daily oral administration of 2 mg dienogest tablets for the treatment of endometriosis in adolescents over a treatment period of 52 weeks

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To demonstrate safety of dienogest (DNG) in the treatment of endometriosis in adolescents

Critère d'inclusion

  • Endometriosis

Liens